Biotechnology

Leerink Swann Advances Investment Banking Franchise with Key New Hires

In addition to these senior bankers, Eric Tansky, Brad Wolff and a team of highly talented mid and junior level bankers from Bank of America Merrill Lynch will be joining the Firm in August.With these additions, Leerink Swann has assembled an experienced senior origination contingent and a complete healthcare investment banking team of approximately 35 …

Leerink Swann Advances Investment Banking Franchise with Key New Hires Read More »

Reportlinker Adds Generic and Biogeneric Drugs for 15 Major Therapeutic Categories

This report reviews, analyzes and sizes the generic and biogeneric drug markets, particularly focusing on new biogeneric medicines. Allergy Drugs CNS and Psychotherapeutic Drugs Analgesics, NSAIDs and Antirheumatic Drugs Cholesterol Reducers Anesthesia Drugs Diabetes Drugs Anti-Convulsants Gastrointestinal Drugs Anti-Infectives Hormonal Drugs Cancer Drugs Osteoporosis Drugs Cardiovascular Drugs Sleeping Agents & Sedatives Primary information for this …

Reportlinker Adds Generic and Biogeneric Drugs for 15 Major Therapeutic Categories Read More »

RedChip Announces Presenter List for February Virtual Equities Conference

ORLANDO, Fla., Feb. 11, 2011 (GLOBE NEWSWIRE) — RedChip Companies, Inc., an international, small-cap research and financial public relations firm, today announced that executives from over 15 emerging small-cap companies, including 12 China growth companies, will offer inside views on their industries and businesses during a virtual conference on February 16 and 17, 2011, from …

RedChip Announces Presenter List for February Virtual Equities Conference Read More »

Silence Therapeutics to Present at Upcoming Investor Conferences

The conferences at which the Company will present are: Rodman & Renshaw 13th Annual Healthcare Conference Sachs Associates 11th Annual Biotech in Europe Investor Conference Silence Therapeutics plc (AIM: SLN) is a leading biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. …

Silence Therapeutics to Present at Upcoming Investor Conferences Read More »

MacAndrews & Forbes Holdings Proposes Merger Transaction in Order to Acquire all M & F Worldwide Shares Not Owned by It

M&F expects that the Company will appoint a special committee of independent directors to consider its proposal and make a recommendation to the Company’s Board of Directors. M&F anticipates that any ensuing transaction will be consummated pursuant to the terms of definitive transaction documents mutually acceptable to M&F and such special committee. M&F will not …

MacAndrews & Forbes Holdings Proposes Merger Transaction in Order to Acquire all M & F Worldwide Shares Not Owned by It Read More »

Bio-Path Holdings to Present at the Biotech Showcase(TM) 2013 Conference

Bio-Path is a biotechnology company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology designed to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Bio-Path’s lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers. The Company announced its plans to conduct three …

Bio-Path Holdings to Present at the Biotech Showcase(TM) 2013 Conference Read More »

Ernesto Echavarria Acquired Shares in Stellar Biotechnologies, Inc.

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Sept. 10, 2013) – Ernesto Echavarria, of Blvd Pedro Ma Anaya #1225, Culiacan Sinaloa, Mexico 80040, has today filed an early warning report dated September 10, 2013 advising of his holdings in Stellar Biotechnologies, Inc. (“Stellar”). Mr. Echavarria has acquired beneficial ownership and control of 1,000,000 common shares of Stellar and …

Ernesto Echavarria Acquired Shares in Stellar Biotechnologies, Inc. Read More »

Research and Markets: National Innovation Ecosystems: Healthcare, CMF, Energy Insights in United States, Germany & South Korea

The concept of interaction among organizational, political, economic, environmental, and technological systems and the resulting synergy has resulted in a new way to support business growth. This phenomenon is being depicted under the term Innovation Ecosystems. Based on the intensity of innovations in the various innovation belts or regions for each technology cluster, the United …

Research and Markets: National Innovation Ecosystems: Healthcare, CMF, Energy Insights in United States, Germany & South Korea Read More »

Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog

Arrayit has enhanced its patented and proprietary microarray platform to accelerate the analysis of the human genome and proteome, which are the blueprints that carry out the inherited and real-time instructions of the human body and impart the function of all living organisms. Deeper genomic and proteomic information is leading to pre-symptomatic diagnostic tests, safer …

Arrayit Corporation Debuts Major New Genomics and Proteomics Products in 2015/2016 Catalog Read More »

Focus on Effective Drug Discovers Expected to Fuel the Demand for High Content Screening Instruments

High Content Screening (HCS) systems are expected to reach 988 installations by 2025; Asia Pacific and Latin America are expected to be the most lucrative markets for high content screening systems. Future Market Insights (FMI), with sharp focus on emerging regions, delivers key insights on the global High Content Screening Market in its latest report …

Focus on Effective Drug Discovers Expected to Fuel the Demand for High Content Screening Instruments Read More »

Viral Clearance Market worth 510.3 Million USD by 2020 — Research and Markets

The global viral clearance market is segmented on the basis of method, end user, application, and geography. Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market. For instance, the number of new biologics products launched annually witnessed a strong …

Viral Clearance Market worth 510.3 Million USD by 2020 — Research and Markets Read More »

Global Kidney Cancer Drug Market Worth USD 4.5 Billion by 2022 – Analysis, Technologies & Forecasts Report 2016-2022 – Vendors: Active Biotech, Amgen, Bayer – Research and Markets

The global kidney cancer drug market is estimated to reach by USD 4.5 billion at a CAGR of 6.2% till 2022. Growing prevalence for lifestyle tempted diseases such as excessive drinking and smoking coupled with chronic diseases such as kidney cancer and tumor are some of the driving factors which are responsible for the growth …

Global Kidney Cancer Drug Market Worth USD 4.5 Billion by 2022 – Analysis, Technologies & Forecasts Report 2016-2022 – Vendors: Active Biotech, Amgen, Bayer – Research and Markets Read More »

Research Reports Coverage on Biotech Stocks — Genetic Technologies, Alder Biopharma, BioDelivery Sciences, and Egalet

Genetic Technologies Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities …

Research Reports Coverage on Biotech Stocks — Genetic Technologies, Alder Biopharma, BioDelivery Sciences, and Egalet Read More »

Asymmetrex Proposes Its Technology for Certifying Therapeutic Stem Cell Dose and Quality To Support Anticipated New FDA Policies for Experimental Stem Cell Treatments

BOSTON (PRWEB) October 24, 2017 Asymmetrex, LLC is a Massachusetts life sciences company with a focus on developing technologies to advance stem cell medicine. Asymmetrex’s founder and director, James L. Sherley, M.D., Ph.D. is an internationally recognized expert on the unique properties of adult tissue stem cells. The company’s patent portfolio contains biotechnologies that solve …

Asymmetrex Proposes Its Technology for Certifying Therapeutic Stem Cell Dose and Quality To Support Anticipated New FDA Policies for Experimental Stem Cell Treatments Read More »

Wired News – Anavex Life Sciences To Commence Phase-2 Study of ANAVEX(R)2-73 in Parkinson”s Disease Dementia

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Anavex Life Sciences most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below: Parkinson’s Disease is a common …

Wired News – Anavex Life Sciences To Commence Phase-2 Study of ANAVEX(R)2-73 in Parkinson”s Disease Dementia Read More »

Applied NeuroSolutions Announces Promising Results for a Blood-Based Test for Alzheimer”s Disease

Peter Davies, Ph.D., the Company’s founding scientist and the Burton P. and Judith Resnick Professor of Alzheimer’s Disease Research at Albert Einstein College of Medicine, commented, “In reviewing both data sets, I am delighted to see a signal that is directly linked to the pathology of Alzheimer’s disease that can potentially distinguish AD from controls. …

Applied NeuroSolutions Announces Promising Results for a Blood-Based Test for Alzheimer”s Disease Read More »

BIO/Ipreo Release New Study Showing Investors Optimistic on Biotech”s Future

“This survey illustrates the long-term confidence that investors have in our industry while detailing the various challenges that impact valuation,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO. “The data will provide considerable insight into current investor perceptions of the industry that may be helpful in anticipating the sector’s …

BIO/Ipreo Release New Study Showing Investors Optimistic on Biotech”s Future Read More »

AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug

“This agreement with Maxwell represents a strong vote of confidence in our technology and also assures the resources to move AHRO-001 into the clinic, not only for Phase I, but also for Phase II human studies,” said Thomas W. Gardner, CEO of AtheroNova. “Maxwell has committed to fund these clinical studies following extensive due diligence …

AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug Read More »

Polydex Pharmaceuticals Issues First Quarter Financial Results Showing a Return to Profitability

The company’s long-standing reputation for consistent high-grade product has generated increasing interest in the company’s core product line from both new and existing customers on a worldwide basis, resulting in an increased level of orders. “It’s great to see a return to profitability,” says George Usher, President and CEO. “The plant is operating around the …

Polydex Pharmaceuticals Issues First Quarter Financial Results Showing a Return to Profitability Read More »

Zafgen Appoints 20-Year Biotechnology Industry Veteran Patricia Allen, CPA, as Chief Financial Officer

Ms. Allen offers 20 years of financial leadership experience in the biotechnology industry at both publicly traded and private companies. For the past two years, she has provided independent consulting services to biotechnology companies in a variety of areas, including interim CFO services, fundraising, deal structures, financial planning, organizational structure, investor relations and business development. …

Zafgen Appoints 20-Year Biotechnology Industry Veteran Patricia Allen, CPA, as Chief Financial Officer Read More »

Fibromyalgia – Pipeline Review, H2 2013: New research report available at Fast Market Research

Global Markets Direct’s, ‘Fibromyalgia – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Fibromyalgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fibromyalgia. Fibromyalgia – Pipeline Review, …

Fibromyalgia – Pipeline Review, H2 2013: New research report available at Fast Market Research Read More »

RepliCel Life Sciences to Present at Biotech Showcase(TM) 2014

About the Biotech Showcase The Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives. About RepliCel Life Sciences RepliCel is a clinical stage biopharmaceutical company focused on developing autologous cell therapies. RepliCel …

RepliCel Life Sciences to Present at Biotech Showcase(TM) 2014 Read More »

TWi Biotechnology Selects Medidata”s Cloud-Based Platform to Advance Cutting-Edge Clinical Development

“The Medidata platform has been broadly adopted globally and using it allows TWi to be more efficient, while ensuring investigative sites and clinical research coordinators are familiar and engaged with the technology,” said Dr. Calvin Chen, TWi Biotechnology’s president. “We’re pleased to be collaborating with Medidata as we work to address unmet medical needs and …

TWi Biotechnology Selects Medidata”s Cloud-Based Platform to Advance Cutting-Edge Clinical Development Read More »

Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President

Schultz is currently a member of the TSRI faculty, as well as Director of the California Institute for Biomedical Research (Calibr). He is also a successful entrepreneur and has led major drug discovery efforts in both the commercial and nonprofit sectors. “After 16 years on the faculty, I am delighted with the opportunity to give …

Scripps Research Institute Names Peter Schultz as CEO, Steve Kay as President Read More »

Automated Microscopy Market – Global Industry Size, Demand and Analysis 2016 – 2020

Microscopy is the technique used to magnify the objects which are not in the resolution range of eyesight. Microscopy works on terms such as diffraction, reflection, electromagnetic radiation, refraction. Automated microscopy is a computer based microscopy in which automated system works on the samples. The basic function of microscopy is magnifying biological samples, to study …

Automated Microscopy Market – Global Industry Size, Demand and Analysis 2016 – 2020 Read More »

Global Automotive Filters Market Size is expected to reach $9.79 billion by 2023: Global Market Insights, Inc.

Ecological problems caused due to emissions of hazardous gases in traditional vehicles has created requirement to produce ecological friendly substitutes. Electric vehicles sector is predicted to witness high expansion prospects due to rising consumer demand for less functional costs & maintenance costs in comparison to fuel powered automobiles. This is predicted to pose a threat …

Global Automotive Filters Market Size is expected to reach $9.79 billion by 2023: Global Market Insights, Inc. Read More »

Lyft and Continuum Announce Partnership for Clinical Trial Transportation Solutions

Continuum Clinical has partnered with ride-share giant Lyft to help provide transportation solutions for patients enrolled in clinical trials. (Photo: Business Wire) This partnership represents the first of its kind among pharmaceutical vendors who work on behalf of pharmaceutical companies to recruit patients for clinical trials. “We’re thrilled to partner with Lyft to offer patients …

Lyft and Continuum Announce Partnership for Clinical Trial Transportation Solutions Read More »

Award-Winning Journalist And Cancer Survivor Joan Lunden Partners With Amgen To Launch At Home With Joan To Empower Patients Battling Cancer

“While I’ve been on thousands of assignments throughout my career, I feel that perhaps my most important one is my current mission to educate and empower others to better understand their cancer and treatment options available so that they can play an active role in their care,” said Lunden. “With so much information out there …

Award-Winning Journalist And Cancer Survivor Joan Lunden Partners With Amgen To Launch At Home With Joan To Empower Patients Battling Cancer Read More »